Commonwealth Equity Services, LLC Homology Medicines, Inc. Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022
SELL
$1.39 - $3.12 $3,775 - $8,473
-2,716 Reduced 20.42%
10,582 $20,000
Q1 2022

May 04, 2022
BUY
$2.6 - $4.17 $1,302 - $2,089
501 Added 3.91%
13,298 $40,000
Q4 2021

Jan 31, 2022
BUY
$3.64 - $7.78 $3,767 - $8,052
1,035 Added 8.8%
12,797 $46,000
Q3 2021

Oct 29, 2021
BUY
$6.01 - $8.71 $70,689 - $102,447
11,762 New
11,762 $92,000

Others Institutions Holding FIXX

# of Institutions
3
Shares Held
66.2K
Call Options Held
0
Put Options Held
0
View Full List

About Homology Medicines, Inc.

FIXX Quotes by TradingView
  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email